Search research articles
Contact Us
Filters
Showing results (1-10 of 121) with videos related to
Page
of 13
Sort By:
Journal of Hepatology
|
August 29, 2020
Reply to: "Evaluating the role of transient elastography post chronic hepatitis C treatment to predict hepatocellular carcinoma"
Joan Genescà
Journal of Hepatology
|
June 5, 2020
Reply to: "Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?" and "External validation of noninvasive predictors of hepatocellular carcinoma in patients with HCV advanced chronic liver disease after oral antivirals"
Joan Genescà
Disease Markers
|
November 3, 2011
Diagnostic and prognostic markers in liver cirrhosis
Salvador Augustin, Joan Genescà
Medicina Clinica
|
April 24, 2004
[Cytokines and liver cirrhosis]
Joan Genescà, Maria Buti
Gastroenterology
|
October 14, 2018
Reply
Macarena Simón-Talero, Joan Genescà
World Journal of Hepatology
|
December 17, 2010
Acute esophageal variceal bleeding: Current strategies and new perspectives
Salvador Augustin, Antonio González, Joan Genescà
Hepatology (Baltimore, Md.)
|
March 13, 2014
Reply: To PMID 23908019
Cristina Ripoll, Joan Genescà, Jaime Bosch
The American Journal of Gastroenterology
|
July 6, 2004
Validation of automated blood cell counters for the diagnosis of spontaneous bacterial peritonitis
Ferran Cereto, Joan Genescà, Rosa Segura
Journal of Hepatology
|
April 23, 2021
Do we need to re-define the Baveno VI elastography criteria for compensated advanced chronic liver disease (cACLD)?
Joan Genescà, Juan G Abraldes, Jaime Bosch
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 19, 2015
α1 and α2-adrenergic agonists on cirrhotic patients with refractory ascites
Meritxell Ventura-Cots, Begoña Santos, Joan Genescà
Page
of 13
Search research articles
Search
Showing results (1-10 of 121) with videos related to
Sort By:
Page
of 13
Journal of Hepatology
|
August 29, 2020
Reply to: "Evaluating the role of transient elastography post chronic hepatitis C treatment to predict hepatocellular carcinoma"
Joan Genescà
Journal of Hepatology
|
June 5, 2020
Reply to: "Hepatocellular carcinoma surveillance after hepatitis C virus eradication: Is liver stiffness measurement more useful than laboratory fibrosis markers?" and "External validation of noninvasive predictors of hepatocellular carcinoma in patients with HCV advanced chronic liver disease after oral antivirals"
Joan Genescà
Disease Markers
|
November 3, 2011
Diagnostic and prognostic markers in liver cirrhosis
Salvador Augustin, Joan Genescà
Medicina Clinica
|
April 24, 2004
[Cytokines and liver cirrhosis]
Joan Genescà, Maria Buti
Gastroenterology
|
October 14, 2018
Reply
Macarena Simón-Talero, Joan Genescà
World Journal of Hepatology
|
December 17, 2010
Acute esophageal variceal bleeding: Current strategies and new perspectives
Salvador Augustin, Antonio González, Joan Genescà
Hepatology (Baltimore, Md.)
|
March 13, 2014
Reply: To PMID 23908019
Cristina Ripoll, Joan Genescà, Jaime Bosch
The American Journal of Gastroenterology
|
July 6, 2004
Validation of automated blood cell counters for the diagnosis of spontaneous bacterial peritonitis
Ferran Cereto, Joan Genescà, Rosa Segura
Journal of Hepatology
|
April 23, 2021
Do we need to re-define the Baveno VI elastography criteria for compensated advanced chronic liver disease (cACLD)?
Joan Genescà, Juan G Abraldes, Jaime Bosch
Liver International : Official Journal of the International Association for the Study of the Liver
|
August 19, 2015
α1 and α2-adrenergic agonists on cirrhotic patients with refractory ascites
Meritxell Ventura-Cots, Begoña Santos, Joan Genescà
Page
of 13